At the J.P. Morgan Healthcare Conference, Nvidia announced major AI partnerships with Lilly and Thermo Fisher Scientific to ...

Eli Lilly and Nvidia, two primary drivers of the recent stock market rally, are deepening their alliance to connect silicon ...

Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to ...

In numerous scientific fields, high-throughput experimentation methods combined with artificial intelligence (AI) show great ...

Nvidia expands BioNeMo for AI drug discovery with new models, tools, and lab partnerships to automate experiments and speed ...

Thermo Fisher Scientific is starting 2026's J.P. Morgan Healthcare Conference with a bang, announcing two new deals with an ...

Dhruv Shenai investigates how machine learning and lab automation are transforming materials science at Cambridge ...

In addition, Der Simulierte Mensch (Si-M), The Simulated Human, a new research center, is being finalized in Berlin to open in 2026. Neubauer explains this is a joint partnership between TU Berlin and ...

Autonomy, by contrast, is about decision‑making and adaptation. The leap from automation to autonomy is not just more actuators; it is a system that can perceive its environment, reason about options, ...

South San Francisco is poised to become an even hotter address for biotech and chip companies. Nvidia and Eli Lilly said ...

Expanded our physical footprint to 20 major cities and integrated 50%+ new experiences. TORONTO, ON AND NEW YORK, NY / ...

Key market opportunities in the electronic lab notebook AI segment include increased demand for real-time tracking, ...